Mario F. Mendez, M.D./Ph.D.

Neurology UCLA School of Medicine, Los Angeles, CA, United States 
"Mario Mendez"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Staffaroni AM, Quintana M, Wendelberger B, et al. (2022) Temporal order of clinical and biomarker changes in familial frontotemporal dementia. Nature Medicine
Meysami S, Raji CA, Mendez MF. (2022) Quantified Brain Magnetic Resonance Imaging Volumes Differentiate Behavioral Variant Frontotemporal Dementia from Early-Onset Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Meysami S, Raji CA, Merrill DA, et al. (2021) Quantitative MRI Differences Between Early versus Late Onset Alzheimer's Disease. American Journal of Alzheimer's Disease and Other Dementias. 36: 15333175211055325
Apostolova LG, Aisen P, Eloyan A, et al. (2021) The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Mendez MF. (2021) The Relationship Between Anxiety and Alzheimer's Disease. Journal of Alzheimer's Disease Reports. 5: 171-177
Rojas JC, Wang P, Staffaroni AM, et al. (2021) Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration. Neurology
Mendez MF. (2021) Frontotemporal Dementia: A Window to Alexithymia. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych201002
Chu SA, Flagan TM, Staffaroni AM, et al. (2020) Brain volumetric deficits in MAPT mutation carriers: a multisite study. Annals of Clinical and Translational Neurology
Mendez MF, Chavez D, Desarzant RE, et al. (2020) Clinical Features of Late-onset Semantic Dementia. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 33: 122-128
Toller G, Ranasinghe K, Cobigo Y, et al. (2020) Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials. Neurology
See more...